Start up Profile

OncoStem Diagnostics was founded with the vision of developing innovative multimarker prognostic & predictive tests to enable personalized treatment planning for patients with Cancer. OncoStem's mission is to become the leading Oncology Diagnostics Company of the 21st century.

OncoStem's focus is on developing tests to identify patterns of recurrence in various cancers. While most cancer treatment is primarily geared toward preventing cancer recurrence, the knowledge of a patient's risk of recurrence is critical in tailoring personalized therapeutic strategies. OncoStem's first focus has been the development of CanAssist-Breast which identifies the risk of recurrence in patients with Hormone Receptor positive Breast Cancer. Similar tests in Oral, Lung, and Colorectal Cancer are under development.

OncoStem's long-term goal is to improve cancer treatment using precision medicine tools. Our tests have been designed and developed with the vision of being used as companion diagnostics to new targeted therapies in the future. OncoStem is currently working towards identifying and characterizing novel drug targets for Breast and Oral Cancer.